The burden of migraine to the individual sufferer: a review
- PMID: 10210887
- DOI: 10.1046/j.1468-1331.1998.560525.x
The burden of migraine to the individual sufferer: a review
Abstract
This review of the literature reveals that migraine is a common, chronic condition featuring episodic attacks which vary in severity and symptomatology. Throbbing, unilateral headache, which is aggravated by activity, is the most prominent feature, although a high proportion of sufferers also experience phonophobia, photophobia and nausea, which may lead to vomiting. Preceding aura is a less common feature of the attack. The frequency and duration of migraine attacks varies widely between individuals, though the median frequency is around 1 attack per month and median duration is roughly 24 h. Migraine attacks can have a profound effect on the day-to-day lives and well-being of the sufferer. In the long term, migraine may cause profound emotional changes and result in coping strategies that interfere with working, social and family life and many normal daily activities. These effects are apparent in quality of life studies on migraine patients. Thus, the impact of migraine on many quality of life parameters is similar to that of other chronic conditions such as osteoarthritis, diabetes and depression. Reduction in the personal burden of migraine can be facilitated by encouraging migraine sufferers to consult their doctor, through accurate diagnosis of migraine headaches and assessment of the disability suffered by the migraineurs, and through improved and well-executed treatment strategies. Copyright 1998 Lippincott Williams & Wilkins
Similar articles
-
Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life.Headache. 2018 Jul;58(7):1007-1013. doi: 10.1111/head.13330. Epub 2018 Jun 7. Headache. 2018. PMID: 29877580
-
Migraine changes with age: IMPACT on migraine classification.Headache. 2006 Jul-Aug;46(7):1161-71. doi: 10.1111/j.1526-4610.2006.00444.x. Headache. 2006. PMID: 16866720
-
Migraine Headache.2024 Jul 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jul 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32809622 Free Books & Documents.
-
The not so hidden impact of interictal burden in migraine: A narrative review.Front Neurol. 2022 Nov 3;13:1032103. doi: 10.3389/fneur.2022.1032103. eCollection 2022. Front Neurol. 2022. PMID: 36408525 Free PMC article. Review.
-
Migraine symptoms: results of a survey of self-reported migraineurs.Headache. 1995 Jul-Aug;35(7):387-96. doi: 10.1111/j.1526-4610.1995.hed3507387.x. Headache. 1995. PMID: 7672955 Review.
Cited by
-
MIDAS (Migraine Disability Assessment): a valuable tool for work-site identification of migraine in workers in Brazil.Sao Paulo Med J. 2002 Jul 4;120(4):118-21. doi: 10.1590/s1516-31802002000400006. Sao Paulo Med J. 2002. PMID: 12436159 Free PMC article.
-
Adverse reactions related to drugs for headache treatment: clinical impact.Eur J Clin Pharmacol. 2005 Feb;60(12):893-900. doi: 10.1007/s00228-004-0864-7. Epub 2005 Jan 19. Eur J Clin Pharmacol. 2005. PMID: 15657778
-
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process.Cephalalgia. 2022 Nov;42(13):1387-1396. doi: 10.1177/03331024221110102. Epub 2022 Jul 5. Cephalalgia. 2022. PMID: 35791285 Free PMC article. Review.
-
Migraine Disability, Quality of Life, and Its Predictors.Ann Neurosci. 2020 Jan;27(1):18-23. doi: 10.1177/0972753120929563. Epub 2020 Jul 3. Ann Neurosci. 2020. PMID: 32982095 Free PMC article.
-
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.CNS Drugs. 2007;21(1):73-82. doi: 10.2165/00023210-200721010-00006. CNS Drugs. 2007. PMID: 17190530
LinkOut - more resources
Full Text Sources
Miscellaneous